论文信息 - Su2091 Results of a Phase II, Randomized, Double Blind, Controlled Trial of the Efficacy of Active Therapeutic Immunization With TNF-Kinoid in Patients With Moderate to Severe Crohn's Disease With Secondary Resistance to TNFα Antagonist - 字舞流文

Su2091 Results of a Phase II, Randomized, Double Blind, Controlled Trial of the Efficacy of Active Therapeutic Immunization With TNF-Kinoid in Patients With Moderate to Severe Crohn's Disease With Secondary Resistance to TNFα Antagonist

O. Dewit | P. Rutgeerts | S. Vermeire | M. Goetz | G. D'Haens | X. Hébuterne | D. S̆timac | M. Allez | Y. Bouhnik | M. Reinshagen | J. Colombel | P. Vandepapelière | J. Bureš | A. Pace | J. Dupas | S. Howaldt | J. Klaus | P. Hoffmann | A. V. Bodegraven | S. Schreiber | S. Kahi